Drug Profile
Research programme: temperature-stable vaccines - Cambridge Biostability
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cambridge Biostability
- Class AIDS vaccines; Parasitic vaccines; Tuberculosis vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; Malaria; Smallpox; Tuberculosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in United Kingdom (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in United Kingdom (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Smallpox in United Kingdom (Parenteral, Injection)